Home
Stocks
Cloudbreak Pharma, Inc.
Filings
Cloudbreak Pharma, Inc. (HKEX:2592) Filings
Cloudbreak Pharma, Inc.
Filings
Filing
Date
Type
Filed with
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Nov 13, 2026
Other filings
HKEX
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE IN RELATION TO THE TOPLINE RESULTS FROM THE PHASE 3 STUDY OF CBT-001 IN PATIENTS WITH PTERYGIUM
Nov 4, 2026
Operations update
HKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Monthly return
HKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Monthly return
HKEX
FORMATION OF AN INDEPENDENT SPECIAL COMMITTEE; DELAY IN PUBLICATION AND DESPATCH OF 2026 INTERIM REPORT; AND CONTINUED SUSPENSION OF TRADING
Sep 30, 2026
Trading halt or suspension
HKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Sep 23, 2026
List of directors
HKEX
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CONTINUED SUSPENSION OF TRADING
Sep 23, 2026
Trading halt or suspension
HKEX
BUSINESS UPDATES AND SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2025 ANNUAL REPORT
Sep 18, 2026
Annual report
HKEX
SUSPENSION OF TRADING
Sep 18, 2026
Trading halt or suspension
HKEX